Julia C Espel1, Hannah L Palac2, Ankit Bharat3, Joanne Cullina4, Michelle Prickett1, Marc Sala1, Susanna A McColley4, Manu Jain5. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. 2. Department of Preventive Medicine, Northwestern University, Chicago, IL, United States. 3. Division of Thoracic Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. 4. Lurie Children's Hospital, Chicago, IL, United States. 5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. Electronic address: m-jain@northwestern.edu.
Abstract
RATIONALE: The association between CFTR genotype, sweat chloride and mortality has been inconsistent, but no previous analyses have examined the association stratified by individual genotypes. OBJECTIVES: To evaluate the genotype-specific association between sweat chloride and mortality. METHODS: The CFF Patient Registry was assessed and included all patients in the registry between 1996 and 2012 with at least one F508del allele. We excluded patients without a documented genotype or plausible sweat chloride level. The primary outcome was time to mortality during the observation period. We examined 15 genotypes using the three most prevalent alleles in each of 5 classes. We compared subgroups of sweat chloride using Kaplan-Meier curves, log-rank tests, and multivariable Cox PH models. The overall predictive value of sweat chloride on mortality was assessed using area under the receiver operating characteristic curves. MEASUREMENTS AND MAIN RESULTS: 18,893 subjects met inclusion criteria. Sweat chloride distribution was similar across genotypes in patients with class 1 mutations, but was significantly different across genotypes in mutation classes 2-5. The R117H/F508del genotype patients demonstrated an association between sweat chloride and mortality (HR: 1.32 for every 10mmol/L increase in sweat chloride [95% CI 1.12-1.54]. There were also significant associations in patients with F508del/F508del, I507del/F508del, G551D/F508del and 2789+5G→A/F508del genotypes, though the clinical relevance for these genotypes is unclear. CONCLUSIONS: There is significant variability in sweat chloride distribution across CFTR class 2-5 genotypes. The relationship between sweat chloride and mortality varies by genotype with a relatively strong relationship in R117H/F508del patients.
RATIONALE: The association between CFTR genotype, sweat chloride and mortality has been inconsistent, but no previous analyses have examined the association stratified by individual genotypes. OBJECTIVES: To evaluate the genotype-specific association between sweat chloride and mortality. METHODS: The CFF Patient Registry was assessed and included all patients in the registry between 1996 and 2012 with at least one F508del allele. We excluded patients without a documented genotype or plausible sweat chloride level. The primary outcome was time to mortality during the observation period. We examined 15 genotypes using the three most prevalent alleles in each of 5 classes. We compared subgroups of sweat chloride using Kaplan-Meier curves, log-rank tests, and multivariable Cox PH models. The overall predictive value of sweat chloride on mortality was assessed using area under the receiver operating characteristic curves. MEASUREMENTS AND MAIN RESULTS: 18,893 subjects met inclusion criteria. Sweat chloride distribution was similar across genotypes in patients with class 1 mutations, but was significantly different across genotypes in mutation classes 2-5. The R117H/F508del genotype patients demonstrated an association between sweat chloride and mortality (HR: 1.32 for every 10mmol/L increase in sweat chloride [95% CI 1.12-1.54]. There were also significant associations in patients with F508del/F508del, I507del/F508del, G551D/F508del and 2789+5G→A/F508del genotypes, though the clinical relevance for these genotypes is unclear. CONCLUSIONS: There is significant variability in sweat chloride distribution across CFTR class 2-5 genotypes. The relationship between sweat chloride and mortality varies by genotype with a relatively strong relationship in R117H/F508delpatients.
Authors: Edith T Zemanick; Michael W Konstan; Donald R VanDevanter; Steven M Rowe; J P Clancy; Katherine Odem-Davis; Michelle Skalland; Nicole Mayer-Hamblett Journal: J Cyst Fibros Date: 2021-02-08 Impact factor: 5.482
Authors: Marc A Sala; Michael Alexander; Basil Khuder; Yuliya Politanska; Hiam Abdala-Valencia; G R Scott Budinger; Jing Liu; Manu Jain; Paul A Reyfman Journal: J Cyst Fibros Date: 2021-01-23 Impact factor: 5.527
Authors: Karen S Raraigh; Kathleen C Paul; Jennifer L Goralski; Erin N Worthington; Anna V Faino; Stanley Sciortino; Yiting Wang; Melis A Aksit; Hua Ling; Derek L Osorio; Frankline M Onchiri; Shivani U Patel; Christian A Merlo; Kristina Montemayor; Ronald L Gibson; Natalie E West; Amita Thakerar; Robert J Bridges; David N Sheppard; Neeraj Sharma; Garry R Cutting Journal: JCI Insight Date: 2022-03-22
Authors: Tyler R Ray; Maja Ivanovic; Paul M Curtis; Daniel Franklin; Kerem Guventurk; William J Jeang; Joseph Chafetz; Hannah Gaertner; Grace Young; Steve Rebollo; Jeffrey B Model; Stephen P Lee; John Ciraldo; Jonathan T Reeder; Aurélie Hourlier-Fargette; Amay J Bandodkar; Jungil Choi; Alexander J Aranyosi; Roozbeh Ghaffari; Susanna A McColley; Shannon Haymond; John A Rogers Journal: Sci Transl Med Date: 2021-03-31 Impact factor: 17.956